期刊
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
卷 36, 期 1, 页码 1-14出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/14756366.2020.1838499
关键词
FBLD; MD; NMR; Bcl-XL; SuMD
资金
- University of Padova under the STARS Grants program [SUMD4FBDD, Euros 131.800]
- PRID-J program (DSF, UNIPD) [stur_sid17_01]
- grant P-DiSC from the University of Padova [01BIRD2018-UNIPD]
Fragment-based lead discovery is an efficient method for developing new drugs. The new computational protocol HT-SuMD allows for automatic screening of thousands of fragments, showing remarkable agreement with NMR-based screening. Virtual screening on a larger library of fragments confirmed all selected hits as Bcl-X-L binders, representing the largest computational fragment screening based on MD to date.
Fragment-based lead discovery (FBLD) is one of the most efficient methods to develop new drugs. We present here a new computational protocol called High-Throughput Supervised Molecular Dynamics (HT-SuMD), which makes it possible to automatically screen up to thousands of fragments, representing therefore a new valuable resource to prioritise fragments in FBLD campaigns. The protocol was applied to Bcl-X-L, an oncological protein target involved in the regulation of apoptosis through protein-protein interactions. Initially, HT-SuMD performances were validated against a robust NMR-based screening, using the same set of 100 fragments. These independent results showed a remarkable agreement between the two methods. Then, a virtual screening on a larger library of additional 300 fragments was carried out and the best hits were validated by NMR. Remarkably, all the in silico selected fragments were confirmed as Bcl-X-L binders. This represents, to date, the largest computational fragments screening entirely based on MD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据